|
Volumn 7, Issue 2, 1997, Pages 153-155
|
2nd International Conference on the Adjuvant Therapy of Malignant Melanoma
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ANTINEOPLASTIC AGENT;
DACARBAZINE;
DOCETAXEL;
GRANULOCYTE COLONY STIMULATING FACTOR;
HYBRID PROTEIN;
INTERFERON;
INTERLEUKIN 12;
INTERLEUKIN 2;
MELPHALAN;
NAVELBINE;
PACLITAXEL;
TAMOXIFEN;
TAURINE;
TUMOR NECROSIS FACTOR;
VINDESINE;
CANCER ADJUVANT THERAPY;
CANCER IMMUNOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CHOROID MELANOMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG CYTOTOXICITY;
DRUG MEGADOSE;
GENE THERAPY;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPH NODE METASTASIS;
MELANOMA;
MELANOMA CELL;
MULTICENTER STUDY;
PATHOGENESIS;
PRIORITY JOURNAL;
PROGNOSIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
VISCUM ALBUM;
|
EID: 0031004291
PISSN: 09608931
EISSN: None
Source Type: Journal
DOI: 10.1097/00008390-199704000-00010 Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|